Fresenius SE Debt to Equity Ratio 2016-2024 | FSNUY

Current and historical debt to equity ratio values for Fresenius SE (FSNUY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Fresenius SE debt/equity for the three months ending June 30, 2024 was 0.56.
Fresenius SE Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $25.75B $21.11B 1.22
2024-03-31 $26.24B $21.84B 1.20
2023-12-31 $27.74B $21.27B 1.30
2023-09-30 $49.03B $32.96B 1.49
2023-06-30 $49.05B $34.27B 1.43
2023-03-31 $47.64B $34.54B 1.38
2022-12-31 $46.57B $33.95B 1.37
2022-09-30 $46.50B $34.40B 1.35
2022-06-30 $46.91B $34.09B 1.38
2022-03-31 $47.73B $34.32B 1.39
2021-12-31 $50.49B $34.65B 1.46
2021-09-30 $50.58B $33.24B 1.52
2021-06-30 $51.23B $32.69B 1.57
2021-03-31 $49.98B $33.17B 1.51
2020-12-31 $46.40B $29.73B 1.56
2020-09-30 $49.24B $30.63B 1.61
2020-06-30 $46.58B $30.01B 1.55
2020-03-31 $46.35B $29.74B 1.56
2019-12-31 $45.28B $29.77B 1.52
2019-09-30 $44.55B $29.69B 1.50
2019-06-30 $44.45B $28.53B 1.56
2019-03-31 $44.47B $29.34B 1.52
2018-12-31 $48.77B $18.20B 2.68
2018-09-30 $47.56B $17.23B 2.76
2018-06-30 $48.42B $17.15B 2.82
2018-03-31 $48.70B $17.07B 2.85
2017-12-31 $35.51B $24.55B 1.45
2017-09-30 $37.53B $24.88B 1.51
2017-06-30 $35.06B $23.12B 1.52
2017-03-31 $34.63B $23.36B 1.48
2016-12-31 $28.80B $22.60B 1.28
2016-09-30 $27.65B $21.12B 1.31
2016-06-30 $28.65B $20.85B 1.37
2016-03-31 $26.96B $19.87B 1.36
2015-12-31 $27.95B $19.99B 1.40
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.553B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.434B 17.67
DaVita (DVA) United States $12.330B 15.95
Encompass Health (EHC) United States $10.431B 24.59
Chemed (CHE) United States $8.349B 25.66
Elanco Animal Health (ELAN) United States $7.168B 17.06
RadNet (RDNT) United States $5.281B 125.26
Option Care Health (OPCH) United States $3.902B 18.49
Amedisys (AMED) United States $3.169B 22.56
LifeStance Health (LFST) United States $2.939B 0.00
Astrana Health (ASTH) United States $2.900B 45.45
Addus HomeCare (ADUS) United States $2.341B 27.46
U.S Physical Therapy (USPH) United States $1.436B 37.81
Pennant (PNTG) United States $1.099B 44.44
Aveanna Healthcare Holdings (AVAH) United States $1.080B 0.00
Atai Life Sciences (ATAI) Germany $0.227B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00